Atlas Venture

ベンチャーキャピタルCambridge, Massachusetts, USA

Biotech-VC aus Cambridge (USA), der Therapeutika-Unternehmen von der Seed- und Series-A-Phase an selbst gründet, inkubiert und bis zur Wachstumsphase finanziert.

未登録
ステージ
シード – グロース
投資先
79
地域
北米, 欧州

投資方針

  1. アイデア (対象外)
  2. プレシード (対象外)
  3. シード
  4. シリーズA
  5. シリーズB
  6. グロース
業界
ヘルスケア・ライフサイエンス
地域
北米欧州

私たちについて

Atlas Venture gründet und baut seit über 30 Jahren Biotechnologie-Unternehmen auf. Wir arbeiten mit Gründerinnen und Gründern aus den Lebenswissenschaften zusammen und bringen neue wissenschaftliche Erkenntnisse aus aller Welt in die Entwicklung von Medikamenten. Viele unserer Beteiligungen entstehen in unserem eigenen Inkubator, gemeinsam mit Entrepreneurs-in-Residence. Nach eigenen Angaben sind daraus bisher 92 Start-ups hervorgegangen.

Wir arbeiten mit zwei Arten von Fonds: Unsere Early-Stage-Fonds finanzieren Seed- und Series-A-Runden, unsere Opportunity Funds (zuletzt Opportunity Fund III mit 400 Mio. US-Dollar) stellen Wachstumskapital für Unternehmen im Portfolio bereit. Unser Portfolio verzeichnet 43 Börsengänge und 39 Exits durch Übernahmen. Aus Atlas-Unternehmen sind 30 Medikamente hervorgegangen. Unser Sitz ist in Cambridge, Massachusetts.

チーム92

BB
Bruce Booth, DPhil
Partner
KB
Kevin Bitterman, PhD
Partner
MG
Michael Gladstone
Partner
JR
Jason Rhodes
Partner
JF
Jean-François Formela, MD
Partner
DG
David Grayzel, MD
Partner
全92人を表示
AR
Aimee Raleigh, PhD
Principal
MF
Maurizio Fazio, MD, PhD
Principal
SP
Stella Paffenholz, PhD
Senior Associate
JP
Julia Pian, MD
Senior Associate
JF
Justin Feng, PhD
Senior Associate
OC
Ommer Chohan
Chief Financial Officer
PB
Peter Barrett, PhD
Partner Legacy Funds
AV
Akshay Vaishnaw, MD, PhD
Venture Partner
BC
Bob Copeland, PhD
Venture Partner
JG
Jernej Godec, PhD
Venture Partner; Chief Executive Officer, Stealth NewCo
LC
Linda C. Bain
Venture Partner
SR
Simon Read, PhD
Venture Partner; Acting Chief Executive Officer, Judo Bio
RD
Rajesh Devraj, PhD
Venture Partner; President & Chief Executive Officer, Rectify Pharmaceuticals
SR
Steven Robinette, PhD
Venture Partner; Chief Executive Officer, Spolia Therapeutics
JA
Jeff Albers, JD, MBA
Venture Partner
PS
Phillip Samayoa, PhD
Venture Partner; Chief Operating Officer, Ethyreal Bio
PT
Praveen Tipirneni, MD
Venture Partner; Chief Executive Officer, Caldera Therapeutics
CA
Charlie Albright, PhD
Venture Partner
JM
John Maraganore, PhD
Venture Advisor
NH
Nicholas Hoppe, PhD
Associate
LA
Laura Alessio
Director of Portfolio Operations
ES
Eric Schmid, JD
Vice President, Legal Affairs
AD
Andrea DiMella
Senior Vice President, Head of Talent
KM
Kristen Margeson
Vice President of Investor Relations and Marketing
MF
Mike Forkel, CPA
Vice President, Finance
DF
Diana Francis, CPA
Controller
JP
Josh Powers, CPA
Finance Manager
KS
Kyle Shuckerow
Finance Manager
ER
Eleanor Ronan
Manager of Talent and HR Operations
LR
Lainey Rabinow
Executive Assistant
SG
Sarah Gerrish
Executive Assistant
FL
Farah Lewis
Executive Assistant
AL
Angela Lam
Executive Assistant
MG
Meaghan Gallagher
Executive Assistant
KU
Katharine Unangst
Executive Assistant
KD
Kathy Doherty
Receptionist
HR
Haojing Rong, PhD
Entrepreneur-in-Residence; Chief Development Officer, Spolia Therapeutics
SS
Steven Sweeney
Entrepreneur-in-Residence; Chief Executive Officer, Stealth NewCo
NK
Nick Keen, PhD
Entrepreneur-in-Residence; Founder & Chief Scientific Officer, Stealth NewCo
MT
Mark Tebbe, PhD
Entrepreneur-in-Residence; Chief Technology Officer, Spolia Therapeutics
ER
Essra Ridha, MD, FRCP, FFPM
Entrepreneur-in-Residence; President & CMO, Spolia Therapeutics
BM
Brenton Mar, MD, PhD
Entrepreneur-in-Residence; Chief Medical Officer, Stealth NewCo
LW
Liron Walsh, MD
Entrepreneur-in-Residence; SVP of Clinical Development, Stealth NewCo
CB
Caroline Breitbach, PhD
Entrepreneur-in-Residence
VS
Vipin Suri, PhD, MBA
Entrepreneur-in-Residence
SB
Sean Burns, MD
Entrepreneur-in-Residence; Chief Scientific Officer, Stealth NewCo
ET
Eben Tessari
Entrepreneur-in-Residence; Chief Executive Officer, Calixis
ET
Evan Thackaberry, PhD, DABT
Entrepreneur-in-Residence
AS
Alfica Sehgal, PhD
Entrepreneur-in-Residence; Chief Scientific Officer, Judo Bio
TP
Timothy P. Reilly, PhD
Entrepreneur-in-Residence; Head of R&D, Stealth NewCo
WS
Wenlin Shao, PhD
Entrepreneur-in-Residence; Chief Development Officer, Stealth NewCo
AH
Alex Harding, MD, MBA
Entrepreneur-in-Residence; Chief Executive Officer, Stealth NewCo
JT
Jeff Trigilio
Entrepreneur-in-Residence; CFO & CBO, Stealth NewCo
SS
Samantha Singer
Entrepreneur in Residence; Chief Executive Officer and President, Stealth NewCo
SR
Scott Ribich, PhD
Entrepreneur-in-Residence; Chief Scientific Officer, Stealth NewCo
OH
Owen Hughes
Entrepreneur-in-Residence; Chief Executive Officer, Stealth NewCo
DR
Dania Rabah, Ph.D.
Entrepreneur-in-Residence; Co-Founder & CSO, Stealth NewCo
PF
Pascal Fortin, PhD
Entrepreneur-in-Residence; President & CSO, Stealth NewCo
DB
Diana Brainard, MD
Entrepreneur-in-Residence; Chief Executive Officer, Stealth NewCo
CC
Constantine Chinoporos
Atlas Advisor; Executive Chairman, Rectify Pharmaceuticals
JQ
John Quisel, JD, PhD
Atlas Advisor; President & Chief Executive Officer, Disc Medicine
NK
Niranjan Kameswaran, PhD
Atlas Advisor; Chief Executive Officer, Ethyreal Bio
DN
Don Nicholson, PhD
Atlas Advisor; Exec. Chairman, Disc Therapeutics; Former CEO, Nimbus
NM
Natalia Misciattelli, PhD
Atlas Advisor; Chief Executive Officer, AAVantgarde Bio
SV
Shelia Violette, PhD
Atlas Advisor; Founder, Chief Scientific Officer, President of Research, Q32 Bio
GV
George Vlasuk, PhD
Atlas Advisor; Board Director, Nimbus Therapeutics
DK
Douglas Kerr, MD, PhD, MBA
Atlas Advisor; Chief Medical Officer, Dyne Therapeutics
RA
Ram Aiyar, PhD, MBA
Atlas Advisor, Chief Executive Officer & President, Korro Bio
G(
Geraldine (Gerry) Harriman, PhD
Atlas Advisor; Co-Founder and Chief Scientific Officer, HotSpot Therapeutics
ER
Elena Ridloff, CFA
Atlas Advisor; CFO & Head of Corporate Development, Sionna Therapeutics
JC
Jared Cumming, PhD
Atlas Advisor; Chief Scientific Officer, Matchpoint Therapeutics
RP
Rubina Parmar, PhD
Atlas Advisor; Head of Technology, Stealth NewCo
JC
John Cox
Atlas Advisor; President and Chief Executive Officer, Dyne Therapeutics
RH
Robert Hughes, PhD
Atlas Advisor; EVP Drug Discovery & Preclinical Development, Rectify
MI
Mark Iwicki
Atlas Advisor; Board Director, Nimbus, Q32
AT
Andre Turenne
Atlas Advisor; Chief Executive Officer, Matchpoint Therapeutics
JM
Jodie Morrison
Atlas Advisor; Chief Executive Officer, Q32 Bio
GM
Geoff McDonough, MD
Atlas Advisor; Former Chief Executive Officer, Generation Bio
BR
Bernard Ravina, MD
Atlas Advisor; Founder and Chief Executive Officer, Vima Therapeutics
VP
Vishal Patel, PhD
Atlas Advisor; Chief Executive Officer, Triveni Bio
PS
Peter Smith, PhD
Atlas Advisor; Co-founder, President & CEO, Remix Therapeutics
NM
Nello Mainolfi, PhD
Atlas Advisor; Chief Executive Officer and President, Kymera Therapeutics
JD
Judith Dunn, PhD
Atlas Advisor; President and Head of R&D, Vima Therapeutics
VP
Vito Palombella, PhD
Atlas Advisor; Chief Scientific Officer, TRIANA Biomedicines
JM
Jonathan Montagu
Atlas Advisor; Chief Executive Officer, HotSpot Therapeutics
AL
Alex Lugovskoy, PhD
Atlas Advisor; Chief Executive Officer, Diagonal Therapeutics

ポートフォリオ79

全79社を表示